Trial intelligence / Profile preview

Corticosteroids Following Portoenterostomy in Infants With Biliary Atresia

NCT00294684Phase 3Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Nov 2005
Primary completion
Jan 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone injection, prednisolone in biliary atresia, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Nov 2005; status: completed.

02

Drugs

methylprednisolone injectionprednisolone
03

Conditions

biliary atresia

Beyond the preview

Go deeper on NCT00294684.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00294684.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call